ProQR Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.About PRQR
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.
CEODaniel Anton de Boer
CEODaniel Anton de Boer
Employees166
Employees166
HeadquartersLeiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded2012
Founded2012
Employees166
Employees166
PRQR Key Statistics
Market cap252.51M
Market cap252.51M
Price-Earnings ratio-5.10
Price-Earnings ratio-5.10
Dividend yield—
Dividend yield—
Average volume794.15K
Average volume794.15K
High today$2.43
High today$2.43
Low today$2.30
Low today$2.30
Open price$2.35
Open price$2.35
Volume308.01K
Volume308.01K
52 Week high$3.27
52 Week high$3.27
52 Week low$1.07
52 Week low$1.07
Stock Snapshot
As of today, ProQR Therapeutics(PRQR) shares are valued at $2.40. The company's market cap stands at 252.51M, with a P/E ratio of -5.10.
On 2025-12-15, ProQR Therapeutics(PRQR) stock moved within a range of $2.30 to $2.43. With shares now at $2.40, the stock is trading +4.3% above its intraday low and -1.2% below the session's peak.
Trading activity shows a volume of 308.01K, compared to an average daily volume of 794.15K.
Over the past 52 weeks, ProQR Therapeutics(PRQR) stock has traded between a high of $3.27 and a low of $1.07.
Over the past 52 weeks, ProQR Therapeutics(PRQR) stock has traded between a high of $3.27 and a low of $1.07.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own PRQR. This list is generated using Robinhood data, and it’s not a recommendation.